For gut's sake: NLRC4 inflammasomes distinguish friend from foe.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. The Shift of an Intestinal "Microbiome" to a "Pathobiome" Governs the Course and Outcome of Sepsis Following Surgical Injury.Shock (Augusta, Ga.) · 2016
   Review
2. Synthetic immunosurveillance systems: nanodevices to monitor physiological events.Biosensors & bioelectronics · 2014
   Review
3. Responses of macrophages against Salmonella infection compared with phagocytosis.In vitro cellular & developmental biology. Animal · 2013
   Article
4. Modern approaches in probiotics research to control foodborne pathogens.Advances in food and nutrition research · 2012
   Review

Corrections and comments

• Comment on
  NLRC4-driven production of IL-1β discriminates between pathogenic and commensal bacteria and promotes host intestinal defense.2012

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as